The clinical utility and limitations of serum carbohydrate antigen (CA19-9) as a diagnostic tool for pancreatic cancer and cholangiocarcinoma. [electronic resource]
Producer: 20111013Description: 2491-6 p. digitalISSN:- 1573-2568
- Adenoma -- diagnosis
- Bile Duct Neoplasms -- blood
- Bile Ducts, Intrahepatic
- Biomarkers, Tumor -- blood
- CA-19-9 Antigen -- blood
- Cholangiocarcinoma -- blood
- Choledocholithiasis -- blood
- Cholestasis -- blood
- Female
- Humans
- Jaundice -- blood
- Male
- Pancreatic Neoplasms -- blood
- ROC Curve
- Retrospective Studies
- Sensitivity and Specificity
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.